Organization (Industry)
Quidel Corporation (United States)
ClinicalTrials.gov lists Quidel Corporation (United States) as lead sponsor of 10 trials.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Quidel Corporation (United States): 10 lead-sponsored trials and 1 legal-entity registration.
Disease areas (6)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Influenza, Human | 2 |
| Acute Coronary Syndrome | 1 |
| Chest Pain | 1 |
| Glossitis, Benign Migratory | 1 |
| Pain | 1 |
Showing 5 of 6 disease areas.
Trials by start year as sponsor or collaborator (9)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2021 | 1 |
| 2019 | 1 |
| 2017 | 2 |
| 2015 | 1 |
| 2014 | 2 |
| 2013 | 1 |
| 2012 | 1 |
| 2011 | 3 |
| 2006 | 1 |
Recruitment duration, a model prediction: none of the 10 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Journals published in (2)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| American heart journal | 1 |
| Clinical chemistry and laboratory medicine | 1 |
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 87 | 10 | 2024-12-24 |
FDA inspection record (1)
| Latest classification | Inspections |
|---|---|
| VAI | 2 |
FDA recalls (14)
Shown in this order: most recent first.
| Product | Classification | Initiated |
|---|---|---|
| QuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp. | Class II | 2026-04-06 |
| QuickVue: Dipstick Strep A Test: 50T, REF: 20108; 25T, REF: 20125; 50T, SCN, REF: 20108SC | Class II | 2025-06-17 |
| QUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20-U, 20 Tests | Class II | 2024-03-05 |
| QUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20, 20 Tests | Class II | 2024-03-05 |
| The Sofia 2 Flu + SARS Antigen FIA employs immunofluorescence technology in a sandwich design that is used with Sofia 2 to detect nucleocapsid protein from influenza A, influenza B, and SARS-CoV-2. This test allows for the detection of SARS-CoV and SARS-CoV-2, but does not differentiate between the two viruses. | Class II | 2024-01-03 |
Showing 5 of 14 recalls.
FDA import refusals (1)
| Refused import lines | Latest refusal |
|---|---|
| 2 | 2022-11-25 |
Manufacturing and distribution sites (1)
| Facility | Location | Regulators | Member organization |
|---|---|---|---|
| QUIDEL CORP. | SAN DIEGO, US | FDA |
Latest dated events (118)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-04-06 | FDA recall | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
| 2025-06-17 | FDA recall | FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment) |
| 2024-12-24 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2024-08-06 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2024-04-09 | Patent granted | Granted US patents (PatentsView / USPTO) |
Showing 5 of 118 events.
On Scientist.com
Quidel Corporation (United States) is listed as a research supplier in the Scientist.com network.
Service areas
Quidel is a leading manufacturer of diagnostic healthcare solutions serving to enhance the health and well being of people around the globe with well known and respected products that provide healthcare professionals with accurate and cost-effective diagnostic information at the point of care (POC).
- Website
- www.quidel.com
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.
Work with Quidel on Scientist.com
For prices, more details, or to contact Quidel, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.